These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
17. A DNA vaccine for Crimean-Congo hemorrhagic fever protects against disease and death in two lethal mouse models. Garrison AR; Shoemaker CJ; Golden JW; Fitzpatrick CJ; Suschak JJ; Richards MJ; Badger CV; Six CM; Martin JD; Hannaman D; Zivcec M; Bergeron E; Koehler JW; Schmaljohn CS PLoS Negl Trop Dis; 2017 Sep; 11(9):e0005908. PubMed ID: 28922426 [TBL] [Abstract][Full Text] [Related]
18. Comparison of Crimean-Congo Hemorrhagic Fever Virus and Aigai Virus in Life Cycle Modeling Systems Reveals a Difference in L Protein Activity. Pickin MJ; Devignot S; Weber F; Groschup MH J Virol; 2022 Jul; 96(13):e0059922. PubMed ID: 35695578 [TBL] [Abstract][Full Text] [Related]
19. Identification of 2'-deoxy-2'-fluorocytidine as a potent inhibitor of Crimean-Congo hemorrhagic fever virus replication using a recombinant fluorescent reporter virus. Welch SR; Scholte FEM; Flint M; Chatterjee P; Nichol ST; Bergeron É; Spiropoulou CF Antiviral Res; 2017 Nov; 147():91-99. PubMed ID: 29024765 [TBL] [Abstract][Full Text] [Related]